HomeNDC LookupRxCUI directory › RxCUI 1148155

Brompheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 4 MG/ML / phenylephrine... — RxCUI 1148155

RxNorm drug concept · Semantic clinical drug
RxCUI 1148155 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1148155
Official nameBrompheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrompheniramine maleate 4 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution; brompheniramine maleate 4 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution
FDA products mapped3
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Brompheniramine maleate 0.8 MG/ML / dextromethor... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brompheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution RxCUI 1148155

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 7

    The active substance itself — no strength, form, or brand attached yet.

    • Brompheniramine 1767
    • Dextromethorphan 3289
    • Phenylephrine 8163
    • Brompheniramine / dextromethorphan / phenylephrine 1008092
    • Brompheniramine maleate 142427
    • Dextromethorphan hydrobromide 102490
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brompheniramine / dextromethorphan / phenylephrine Oral Solution 405871
    • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution 2646243
    • Brompheniramine / dextromethorphan / phenylephrine Oral Liquid Product 1155715
    • Brompheniramine / dextromethorphan / phenylephrine Oral Product 1155716
    • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product 2662471
    • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product 2659208
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Brompheniramine maleate 0.8 MG/ML 1037162
    • Dextromethorphan hydrobromide 4 MG/ML 1010978
    • Phenylephrine hydrochloride 2 MG/ML 996626

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brompheniramine maleate 0.8 MG/ML SCDC · 1037162
  • Dextromethorphan hydrobromide 4 MG/ML SCDC · 1010978
  • Phenylephrine hydrochloride 2 MG/ML SCDC · 996626
  • Brompheniramine / dextromethorphan / phenylephrine Oral Solution SCDF · 405871
  • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution SCDFP · 2646243
  • Brompheniramine / dextromethorphan / phenylephrine Oral Liquid Product SCDG · 1155715
  • Brompheniramine / dextromethorphan / phenylephrine Oral Product SCDG · 1155716
  • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product SCDGP · 2662471
  • Brompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product SCDGP · 2659208

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1148155 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52083-0237-01 30 mL in 1 BOTTLE (52083-237-01) Tussi Pres B KRAMER NOVIS 2011-03-29
52083-0237-04 120 mL in 1 BOTTLE (52083-237-04) Tussi Pres B KRAMER NOVIS 2011-03-29
52083-0237-16 480 mL in 1 BOTTLE (52083-237-16) Tussi Pres B KRAMER NOVIS 2011-03-29
52083-0637-16 480 mL in 1 BOTTLE (52083-637-16) Presgen B KRAMER NOVIS 2011-03-29
53163-0101-16 473 mL in 1 BOTTLE (53163-101-16) Altipres-B Alternative Pharmacal Corporation 2012-11-01
Observed labelers: KRAMER NOVIS (4) · Alternative Pharmacal Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.